Why the study?
Does lovastatin reduce VLDL abnormalities in patients with moderate hypertriglyceridemia?
Population
Patients with moderate hypertriglyceridemia
Comparison
Lovastatin vs Placebo
Design
Other
Authors
Loading...
May reduce VLDL abnormalities in moderate hypertriglyceridemia; leaves open confirmation of atherosclerotic benefit in trials.
Does lovastatin reduce VLDL abnormalities in patients with moderate hypertriglyceridemia?
Lovastatin reduces VLDL abnormalities and cholesteryl ester content in patients with moderate hypertriglyceridemia, which may help decrease atherosclerotic complications.
Gianturco et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: